| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| apomorphine | alpha-2a adrenergic receptor | small molecule | NA | drugbank , DGIDB | Parkinson Disease[MeSHID:D010300] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.07 | approved,investigational | agonist |
| apomorphine | alpha-2b adrenergic receptor | small molecule | NA | drugbank , DGIDB | Parkinson Disease[MeSHID:D010300] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.08 | approved,investigational | agonist,antagonist |
| apomorphine | alpha-2c adrenergic receptor | small molecule | NA | drugbank , DGIDB | Parkinson Disease[MeSHID:D010300] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.07 | approved,investigational | agonist,antagonist |
| apomorphine | dopamine d1 receptor | small molecule | NA | drugbank , DGIDB | Parkinson Disease[MeSHID:D010300] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.12 | approved,investigational | agonist |
| apomorphine | dopamine d2 receptor | small molecule | Successful target | TTD , drugbank , DGIDB | Parkinson Disease[MeSHID:D010300] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.21 | approved,investigational | agonist |
| apomorphine | dopamine d3 receptor | small molecule | NA | drugbank , DGIDB | Parkinson Disease[MeSHID:D010300] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | approved,investigational | agonist |
| apomorphine | dopamine d4 receptor | small molecule | NA | drugbank , DGIDB | Parkinson Disease[MeSHID:D010300] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.5 | approved,investigational | agonist |
| apomorphine | dopamine d5 receptor | small molecule | NA | drugbank , DGIDB | Parkinson Disease[MeSHID:D010300] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.45 | approved,investigational | agonist |
| apomorphine | 5-hydroxytryptamine receptor 1a | small molecule | NA | drugbank , DGIDB | Parkinson Disease[MeSHID:D010300] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.08 | approved,investigational | agonist |
| apomorphine | 5-hydroxytryptamine receptor 1b | small molecule | NA | drugbank | Parkinson Disease[MeSHID:D010300] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | agonist |
| apomorphine | 5-hydroxytryptamine receptor 1d | small molecule | NA | drugbank | Parkinson Disease[MeSHID:D010300] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | agonist |
| apomorphine | 5-hydroxytryptamine receptor 2a | small molecule | NA | drugbank , DGIDB | Parkinson Disease[MeSHID:D010300] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.06 | approved,investigational | agonist,antagonist |
| apomorphine | 5-hydroxytryptamine receptor 2b | small molecule | NA | drugbank , DGIDB | Parkinson Disease[MeSHID:D010300] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.13 | approved,investigational | agonist,antagonist |
| apomorphine | 5-hydroxytryptamine receptor 2c | small molecule | NA | drugbank , DGIDB | Parkinson Disease[MeSHID:D010300] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.09 | approved,investigational | agonist,antagonist |
| click here to return to the previous page | ||||||||